On Dec 10, the Health Resources and Services Administration (HRSA) released a final rule establishing a process to resolve disputes between 340B-covered entities and drug manufacturers.
This content is restricted to members.
HRSA Releases 340B Drug Pricing Program Administrative Dispute Resolution Final Rule
For CFOs, CMOs, pharmacy managers
